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Abstract The role of cell authentication in biomedical
science has received considerable attention, especially
within the past decade. This quality control attribute is
now beginning to be given the emphasis it deserves by
granting agencies and by scientific journals. Short
tandem repeat (STR) profiling, one of a few DNA
profiling technologies now available, is being proposed
for routine identification (authentication) of human cell
lines, stem cells, and tissues. The advantage of this
technique over methods such as isoenzyme analysis,
karyotyping, human leukocyte antigen typing, etc., is that
STR profiling can establish identity to the individual
level, provided that the appropriate number and types of
loci are evaluated. To best employ this technology, a
standardized protocol and a data-driven, quality-
controlled, and publically searchable database will be
necessary. This public STR database (currently under
development) will enable investigators to rapidly authen-
ticate human-based cultures to the individual from whom
the cells were sourced. Use of similar approaches for
non-human animal cells will require developing other
suitable loci sets. While implementing STR analysis on a
more routine basis should significantly reduce the
frequency of cell misidentification, additional technolo-
gies may be needed as part of an overall authentication
paradigm. For instance, isoenzyme analysis, PCR-based
DNA amplification, and sequence-based barcoding meth-
ods enable rapid confirmation of a cell line’s species of
origin while screening against cross-contaminations,
especially when the cells present are not recognized by
the species-specific STR method. Karyotyping may also
be needed as a supporting tool during establishment of
an STR database. Finally, good cell culture practices
must always remain a major component of any effort to
reduce the frequency of cell misidentification.
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Introduction
Authors submitting manuscripts to high-impact chemistry
journals must specify the methods used to establish the
purity of starting material chemicals for synthesis and other
key components used during a study. The results of such
quality control testing must also be reported, thereby
enabling the reader to judge the validity of the work. Why
is the most important reagent of many cell culture studies—
the cell line itself—often lacking test requirements to
confirm its identity? If the scientific community agrees that
some form of identity testing must be done, what
methodology or methodologies should be used? What
exactly should cell authentication entail?
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biomedical research, cases of cell line misidentification
have emerged. This problem is especially true for contin-
uous cell lines, with the increased probability over time of
mislabeling or cross-contaminating one cell type with
another. Historically, the primary cross-contaminant (e.g.,
Gartler 1967; Nelson-Rees et al. 1974) has been HeLa, a
human cervical carcinoma cell which, given the opportuni-
ty, rapidly outgrows most other cells in culture. In more
recent years, cell lines other than HeLa were implicated in
numerous misidentification examples. For example, the cell
line ECV304 was originally claimed to be a spontaneously
transformed human normal endothelial cell line but was
later shown to be T24 bladder cancer cells (Dirks et al.
1999). The putative human prostate cancer cell lines TSU-
Pr1 and JCA-1 proved to be T24 bladder cancer cells (van
Bokhoven et al. 2001). DNA fingerprinting analysis
demonstrated that the NCI/ADR-RES cell line is actually
an ovarian tumor cell line (OVCAR-8) rather than a breast
cancer cell line (Liscovitch and Ravid 2006). Many other
examples have and continue to be published (Gilbert et al.
1990; Boonstra et al. 2010; Capes-Davis et al. 2010).
What is the impact on biomedical research when
investigators use an incorrectly identified cell line? If the
cell line is a proxy for a more complex animal or human
tissue under investigation, how relevant are the results
obtained when, for example, a bladder cell line is used to
study chemotherapies directed toward prostate cancer?
While such questions are difficult to answer, one can
assume that much time, money, and resources have been
expended in vain due to this issue. Despite these con-
sequences, the problem of cell misidentification does not
appear to be going away (Buehring et al. 2004; Berglind et
al. 2008). Not only continuous cell lines are at risk; the use
of feeder cells for human stem cell propagation and using
xenografts for propagating human tumor cells have provid-
ed additional opportunities for cross-contamination and
misidentification.
Due to the persistent and courageous championship of
Roland Nardone (e.g., Nardone et al. 2007), John Masters
(Masters et al. 2001), and others, granting agencies such as
the NIH are now beginning to stress the importance of cell
authentication (e.g., National Institutes of Health 2007). In
addition, scientific journals, such as International Journal
of Cancer, Cell Biochemistry and Biophysics, In Vitro
Cellular and Developmental Biology-Animal,a n dt h e
journals of the American Association for Cancer Research
are beginning to require the authors to address cell
authentication within submitted manuscripts.
In this article, we discuss the role of short tandem repeat
(STR) profiling within the greater context of cell authen-
tication strategies for reducing the frequency of human and
animal cell misidentification.
Causes of Cell Misidentification
Many scenarios can potentially lead to cell culture
misidentification, and unfortunately, these can play out in
even the most prestigious laboratories. They represent
either human errors (mislabeling, cross-contamination) or
an undesired result of the techniques used (use of feeder
layers or xenografting). Such causes may be expressed as a
principle of inevitability: that is, given human nature and
the nature of cell line maintenance, every laboratory
engaged in cell culture research involving the use of more
than one cell line may inevitably experience misidentifica-
tion/cross-contamination. An extension of this principle is
that the more frequently a culture needs manipulation (e.g.,
have its media adjusted or be passaged or subcultured), the
greater is the probability of misidentification. Therefore,
continuous (immortal; transformed) cultures pose a greater
risk than cells with a finite life span, all other factors being
equivalent. Failure or refusal of scientists to follow the most
basic good cell culture practices (e.g., Masters and Stacey
2007) can only add to the risk of cell misidentification.
The attitude, “I’d just as soon not know,” is alive and
well in many laboratories. The notion is unfathomable that
scientists would knowingly jeopardize their research and
careers by not confirming the identity of one of their most
valuable resources, their cell cultures. Once unauthenticated
cell lines are in use for an extended period and those results
are published, “not knowing” prevents the necessity of
explaining to the scientific community that the published
data may be irrelevant.
In general, human factors furthering the cell line
misidentification problem include failing to both appreciate
the extent of the problem and take the appropriate
preventative measures. Safeguards catching inevitable
operator errors and distractions are absent. The specimens
are neither checked nor verified.
Perhaps the most straightforward cause of cell line
misidentification is the simple mislabeling of a cell culture
vessel during routine manipulation (e.g., passage). The
culture becomes misidentified as a result. Factors contrib-
uting to this type of error might include operator
workload, lack of attention, or distractions while handling
cell lines.
Cross-contamination of one culture with another and
subsequent overgrowth of the culture with the contaminat-
ing cell type is another common cause of cell line
misidentification. The chances of this occurring are in-
creased by sharing reagents, repeatedly using the same
pipette during refeeding operations, and simultaneously
working on multiple cultures without adequately isolating
one culture from another. Theoretically, a cross-
contamination event may result in a spectrum of outcomes,
depending upon the growth characteristics of the contam-
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actual practice, the fastest-growing cell type rapidly out-
grows the other, leading to a relatively pure culture within
four or five passages (Nims et al. 1998).
The intentional establishment of a cocultivation during
propagation of human stem cells using a feeder cell derived
from another species (e.g., mouse) can contribute to the
cross-contamination and overgrowth of the human cells.
Normally, feeder cells are rendered, by various means,
incapable of proliferating. Occasionally, the feeder cells
escape these barriers and proliferate to form mixed cultures,
or eventually, cultures are predominated by the feeder cells.
Also, cultured cells have the potential to pick up DNA
material from “dead” feeder cells. For example, the mantle-
cell lymphoma cell line, NCEB-1, has acquired multiple
murine chromosomes (Camps et al. 2006).
The use of xenografting as a technique for human tumor
cell propagation can also lead to cell line cross-
contamination and misidentification. In this case, the cell
line recovered from the xenograft may occasionally turn out
to consist of or include host animal cells rather than a pure
culture of the human cells originally grafted (Pathak et al.
1999). In fact, when tissues are xenografted into a host
animal, the blood vessels undergo anastomosis to form a
hybrid blood vessel (Murry et al. 1994; Chen et al. 2009).
Cell lines isolated from xenografts would therefore be
prone to cross-contamination.
Good Cell Culture Practices
To prevent cell line cross-contamination, certain good cell
culture practices are absolutely critical. These include the
admonitions to (1) manipulate only one type of cell at a
time, (2) fully decontaminate the work station after
handling one cell line and before working on a second
culture, (3) never enter a reagent (medium, buffer, trypsin,
etc.) more than once with the same pipette, (4) dedicate a
given medium bottle to one specific cell line instead of
sharing it with different cell types, and (5) never share
media bottles with others. The chances of mislabeling a
culture are also increased when two or more different cell
lines are handled at the same time, so following the
recommended practice of manipulating only one type of
cell at a time should help to prevent culture mislabeling as
well. Critical to ensuring culture integrity is the identifica-
tion and remediation of error-prone cell culture practices
that bias towards cross-contamination.
Cell morphology for continuous monolayer cell lines
should remain constant over time and passage number.
Prior to manipulating such a culture, especially if cells from
multiple vessels are to be harvested and pooled, the
morphology of the cells within each monolayer should be
observed. Cultures showing morphological evidence of
cross-contamination should not be used.
Routine observation of culture morphology can be an
especially straightforward way of detecting cross-
contaminated or mislabeled cultures. In fact, observing foci
of altered cell morphology within a monolayer culture may
be the first sign of a recent cross-contamination (Nims and
Herbstritt 2005). Examples of cross-contaminated human
cell cultures in which morphology may be used to
distinguish the mixed cell types are shown in Fig. 1
(HeLa and normal, early passage human fibroblasts).
With permanent cell lines, morphological differences may
not always, however, be sufficient to identify cross-
contamination. Figure 2 shows the mixed culture of a
complex human hybrid cell line (CGL1) (Stanbridge et al.
1981) and a known misidentified cell line “X,” a
morphologically similar specimen to emphasize the poten-
tially insidious nature of cross-contamination problematic
material. Figure 2A, C shows CGL1 and cell line “X”,
respectively, as individual cultures. Figure 2B shows a
mixed culture of the two cell lines. In this case, the
presence of the mixed culture is not readily apparent based
on morphology of the cells alone but is indicated by the
differential staining with CellTracker™ dyes. The STR
profiles from these cultures are shown in Table 1. The
CGL1 hybrid cell line shows both the alleles found in the
HeLa cell line and the human fibroblast GM00077
(originating from a male patient) used in the hybridization.
Even with the complex STR profile found in CGL1, the
profile of the mixed culture, CGL1-“X,” can identify a
contaminating event (Table 1).
Indetectingcross-contaminationeventsinvolvingaspecies
different from the putative specimen, additional technologies
to human-specific STR analysis are required. Tables 2 and 3
Figure 1. Microscopic examination of a mixed culture of early
passage, normal human fibroblasts, and HeLa cell line. The cross-
contamination between normal human fibroblasts and HeLa cells
(ATCC® CCL-2™) is easily detected by microscopic examination for
morphology: the fibroblasts have an orbital shape while HeLa cells
form rounded cell colonies.
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mouse cell mixes remains undetected in human-based
STR analysis. Isoenzyme analysis may both confirm the
existence and determine the animal species of the
contaminant (Nims and Herbstritt 2005). Another more
sensitive technology serving this purpose is DNA ampli-
fication and barcoding (e.g., Cooper et al. 2007). Applied
to the same human/mouse mixes, Table 2 demonstrates
how the polymerase chain reaction (PCR)-based species
identification assay reveals the previously undetected
mouse material. Furthermore, this experiment shows that
human material is detectable even at the 1:100 dilution,
demonstrating the assay’ss e n s i t i v i t y .
Mouse or human feeder cells are used to promote growth
of feeder-layer-dependent human stem cells. By testing for
cross-contamination, the likelihood of contamination with
the feeder cells is reduced. Morphology, in and of itself, is
an unsuitable marker for stem cell line purity, as these
cultures tend to contain multiple characteristics. Dittmar et
al. (2010) demonstrated the utility of STR profiling for
detecting misidentified stem cells. With increasing empha-
sis on clinical applications for stem cells, cell authentication
Figure 2. Microscopic examination of a mixed culture between a
human hybrid cell line (CGL1) and a known misidentified cell line
(“X”). (A) CGL1, a hybrid between HeLa and the human diploid
fibroblast, GM00077 (Coriell, Camden, NJ) (Stanbridge et al. 1981)
stained with CellTracker™ Blue CM (C2111, Invitrogen, Carlsbad,
CA). CellTracker™ dyes are cleaved in the cytoplasm to produce a
fluorescent color. Once cleaved, the dye is trapped inside the cell. This
and the following pictures were taken with ×20 lens using a Nikon
Eclipse TE2000-U microscope. Post-capture processing was done
with Nikon Elements-AR software. (B) A 50:50 mixed culture of
CGL1 and cell line “X,” a known misidentified cell line. Similar
morphologies prevent easy detection of this particular cross-
contamination. A 50:50 mixed culture of CGL1 (stained blue) and
cell line “X” stained with CellTracker™ Red CMTPX (C34552,
Invitrogen) is visually evident only due to the artificial coloration. The
“pure” and mixed cultures were cultured overnight to allow cell
attachment and recovery. (C) This image shows “pure” cell line “X”
stained with CellTracker™ Red.
Table 1. STR profiles for the “pure” cell lines and the mixed culture
Alleles
a HeLa GM00077 CGL1
b CGL1-Cell line “X”
c Cell line “X”
D5S818 11, 12 12 11, 12 11, 12 11, 12
D13S317 12, 13.3 9, 12 9, 12, 13.3 9, 10, 11, 12, 13.3 10, 11
D7S820 8, 12 8, 14 8, 12, 14 8, 10, 12, 14 10, 12
D16S539 9, 10 11, 13 9, 10, 11, 13 9, 10, 11, 12, 13 12
TH01 7 6, 9.3 6, 7, 9.3 6, 7, 9.3 9.3
Am X X, Y X, Y X, Y X, Y
TPOX 8, 12 8, 10 8, 10, 12 8, 10, 12 8
CSF1PO 9, 10 8, 10 8, 9, 10 8, 9, 10, 11, 12, 13 11, 12, 13
aA detailed description of each allele is presented at the following link: http://www.cstl.nist.gov/div831/strbase/str_fact.htm
bNote the differences between HeLa and CGL1. All the HeLa STR markers are found in the CGL1 cell line. The extra markers reflect the contribution from
the diploid fibroblast (GM00077) used in the hybridization. HeLa shows only X chromosome material. CGL1 shows both X and Y chromosome material
cThe mixed culture contains each of the STR markers found in the CGL1 and cell line “X” cultures
814 NIMS ET AL.and characterization become paramount. Training in this
important area should include cell line authentication as
part of good laboratory practices for stem cell culture.
Cultures and/or tissues passaged by xenografting have
the same risk. Host cells may integrate into the graft to
provide the functional support required for growth. There-
fore, cultures maintained or established in this manner have
a high cross-contamination probability with host cells
(Pathak et al. 1999). The only way to rule out the presence
of the host cell type is through isoenzyme analysis, DNA
amplification, and barcoding or some alternative species
identification method on the derived tumor line.
Cell Authentication
In the recent past, cell line species confirmation was the
main authentication approach, primarily performed by
karyotyping or immunological techniques. Later, isoen-
zyme analysis was employed. Isoenzyme analysis has the
advantage that it is rapid and simple and can be used both
to confirm species of origin and detect cross-contaminating
cells if the latter is present at 10% or greater (Nims et al.
1998). In fact, isoenzyme analysis is currently the primary
method employed within the biopharmaceutical industry for
animal cell line authentication to satisfy the 1993 FDA
guidance, entitled “Points to Consider in the Characteriza-
tion of Cell Lines Used to Produce Biologicals” (FDA
1993), and the International Conference on Harmonization
guidance ICH Q5D, entitled “Quality of Biotechnological
Products: Derivation and Characterisation of Cell Sub-
strates Used for Production of Biotechnological/Biological
Products” (International Conference on Harmonization
1998).
Authenticating human cells Isoenzyme analysis generally is
incapable of resolving different human cell lines, with the
exception of the polymorphism for glucose 6-phosphate
dehydrogenase which Gartler (1967) exploited in discover-
ing HeLa-contaminated human cell lines. Classical human
cell authentication supplements isoenzyme analysis with
karyotypic analysis, especially for diploid cell lines.
Sample STR summary results PCR species and cross-contamination results
Human (CRL-5810™) Full profile Human
Mouse (CRL-1642™) Not detected Mouse
1:1 human/mouse Full profile Human, mouse
1:10 human/mouse Some stochastic losses Human, mouse
1:20 human/mouse Some stochastic losses Human, mouse
1:50 human/mouse Some stochastic losses Human, mouse
1:100 human/mouse Heavy stochastic losses Human, mouse
1:500 human/mouse Heavy stochastic losses Mouse
1:1,000 human/mouse Not detected Mouse
Water control Not detected No species detected
Table 2. Human cells (NCI-
H522 [H522]; ATCC® CRL-
5810™), mouse cells (LL/2
(LLC1); ATCC® CRL-1642™),
and various mixes of the two
were subjected to both STR
profiling and cytochrome
oxidase I (COI)-specific PCR
amplification
Table 3. A detailed examination of the STR profiling results shows gradual allelic loss as the mouse DNA increases relative to the human DNA
content
Sample D5S818 D13S317 D7S820 D16S539 vWA TH01 AMEL TPOX CSF1PO
Human (CRL-5810™) 1 1 1 09 , 1 0 1 21 7 7 , 9 . 3 X 9 , 1 0 1 0
Mouse (CRL-1642™) –– –– – – – – –
1:1 Human/mouse 11 10 9, 10 12 17 7, 9.3 X 9, 10 10
1:10 human/mouse 11 10 9, 10 12 17 7, 9.3 X 10 10
1:20 Human/mouse – 10 10 12 17 9.3 X – 10
1:50 Human/mouse 11 10 10 – 17 7 –– –
1:100 Human/mouse 11 –– 12 –– – – –
1:500 Human/mouse –– –– – – – – 10
1:1,000 Human/mouse –– –– – – – – –
Water Control –– –– – – – – –
This loss begins at the 1:10 human/mouse mix (profile is missing TPOX allele 9). The 1:20 through 1:100 human/mouse mixes find some alleles
lost at a higher human concentration, only to reappear at lower concentrations due to stochastic effects. However, a general trend remains: reduced
number of scored alleles as the relative proportion of mouse DNA increases and the proportion of human DNA decreases
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cumbersome techniques, such as HLA typing or chromo-
somal banding analysis. The more recent molecular
diagnostic techniques, namely single-nucleotide polymor-
phism (SNP) typing and STR profiling, enable human cell
authentication to the individual level. These technologies
are now considered viable options for standardizing human
cell authentication (Masters et al. 2001; Parson et al. 2005;
Schweppe et al. 2008; Pakstis et al. 2010). In fact, an
international team of scientists is, at this time, preparing a
consensus standard on human cell authentication using STR
profiling (ATCC 2009; ATCC® SDO Workgroup ASN-
0002 2010; Barralon et al. 2010).
What is STR profiling? STR profiling is an analytical DNA
technique which PCR-amplifies variable microsatellite
regions from a genomic DNA template, separates the PCR
amplicons on a genetic analyzer, and uses software to
analyze the resulting data and compare the data from one
specimen to databases housing previously generated STR
sets. The technology depends on the simultaneous ampli-
fication of multiple stretches of polymorphic DNA within a
single vessel. Repetitive DNA sequences with varying
numbers of repeats, referred to as STR loci, are amplified
using primers with differently colored fluorophores. These
amplicons are distinguished by both size and color (see
Fig. 3). The value of the STR profile is appreciated when
placed into context of the cell culture’s history, the profile’s
similarity to those of derived cell lines, and its uniqueness
to unrelated material. This extremely sensitive and repro-
ducible DNA analysis method has been employed since the
early 1990s by forensic analysts, eventually resulting in the
Federal Bureau of Investigation Laboratory’s Combined
DNA Index System, launched in 1990 and formally adapted
in 1994. STR profiling was chosen for use in the new
human cell authentication Standard (ATCC® SDO Work-
group ASN-0002 2010; Barralon et al. 2010) because it
enables authentication to the individual level, is rapid and
economical, and is amenable to automation. Furthermore,
STR data’s reproducible nature makes them suitable for a
standard reference database. This standard will meet
International Standards Organization guidelines for stand-
ards development and will be recognized by the American
National Standards Institute (ANSI).
Figure 3. STR profile of CGL1. This STR profile example featuring
CGL1 reveals the complexities, such as polyploidy, associated with
hybrid cell lines. The STR procedure follows: Cell pellets (~3.5×10
5
cells each) were resuspended in 200 μL Qiagen Buffer G2. DNA
extraction and purification were conducted on the EZ1 Advanced
robotic system (Qiagen, Germantown, MD); readings on the Nano-
Drop ND-1000 Spectrophotometer (Thermo, Wilmington, DE) pro-
duced DNA concentrations. After normalizing the DNA, 1.0 μLo f
sample was amplified using PowerPlex 1.2 (Promega, Madison, WI)
in an 8.0-μL reaction. An aliquot of the product was mixed with Hi-Di
formamide [Applied Biosystems Inc. (ABI), Foster City, CA] and
Internal Lane Standard (CXR) 60–400 bases (Promega), denatured,
and then fractionated on an ABI 3130xl Genetic Analyzer. Resulting
data were processed and evaluated using ABI Genemapper v3.2.1.
816 NIMS ET AL.The ANSI standard The standard under construction will
provide investigators with guidance on applying STR
analysis to authenticating human cell lines. Such guidance
will include methodological descriptions of DNA sample
preparation, stipulate the appropriate numbers and specific
loci to be evaluated, and detail the interpretation and quality
control of the results. Associated with the standard itself
will be the establishment and maintenance of a public STR
profile database under the auspices of the National Center
for Biotechnology Information.
Proposed paradigm for human cell authentication For
newly developed human primary cell cultures and cell
lines, including feeder-layer-dependent human stem cells
and tumor cells propagated through xenografting, an initial
baseline STR profile must be established on the earliest
material. Baseline material may include biopsy, frozen
tissue, or formalin-fixed paraffin-embedded tissue. For
cancer cell lines, the established cell line may express a
slightly different STR profile than the heterogeneous tumor.
The baseline STR profile for the cell line should also be
determined at the time of the initial cryopreservation.
Whenever possible to obtain patient specimens, derived
from blood or buccal samples, these vouchers powerfully
verify the authenticity of the baseline material. For mouse
feeder-layer-dependent human stem cell preparations, a
DNA amplification and barcoding assay (e.g., Cooper et
al. 2007), an isoenzyme analysis assay, or alternative
method may need to be performed to demonstrate that
there are no cross-contaminating mouse feeder cells in the
preparation. To demonstrate the recovered tumor cell line’s
purity, additional testing may also be necessary in cases
involving xenografted material. Laboratories employing
continuous cell lines derived from both human and non-
human animal species will need to monitor cross-
contamination using one of the cell species identification
methods.
For existing human cell lines, investigators will be
encouraged to (1) check the universal database to see if
the cell line is represented within the public STR database,
(2) ensure that the STR database indicates that this cell line
is not misidentified, and (3) perform an STR analysis and
compare the results to those within the STR database. Once
completed, the ANSI standard will provide the necessary
matching criteria (ATCC® SDO Workgroup ASN-0002
2010).
How often should authentication be performed? This is a
question which most likely will not be specified explicitly
within the standard. Common sense will have to be applied
by the investigator. We recommend performing authentica-
tion when a cell line is received from an outside source
(repository, other investigator). An aliquot could be tested
at the time of preparation of the initial frozen cell stock.
The culture should have its profile reconfirmed after
expanding two or three passages, to check if any contam-
inants previously below the detection threshold have grown
to be more evident (Fig. 4). Cells from the initial frozen
stock may then be used for experiments with confidence
that the identity is correctly established. The identity of the
cell line should be reconfirmed when new cell stocks are
prepared. For newly established cultures, a sample of the
Figure 4. Detection of intraspecies cell mixtures using PCR
amplification. Cross-contamination between frequently used cell lines
of different species is easily detected using PCR-based species
identification assays. Depending on the organism, the species-
specific primers target either the cytochrome oxidase I or the
cytochrome B genes. In this example, mixtures of human (NCI-
H522 [H522]; ATCC® CRL-5810™) and mouse cells (LL/2 (LLC1);
ATCC® CRL-1642™) were created at various ratios and were
analyzed via multiplex PCR. The presence of human cells was
detected using a set of primers specific for the human COI target (a),
while the presence of the mouse contaminant cells was detected using
a multiplex PCR targeting 11 non-human species (cat, Chinese
hamster, rhesus monkey, horse, cow, African green monkey, rat, goat,
dog, New Zealand rabbit, and mouse) (b). Human band 391 bp; mouse
band 150 bp; internal control 70 bp. Abbreviations used: M Invitrogen
100 bp ladder; NTC no template control. These results, together with
STR profiling for the cell line mixtures, are also summarized in
Table 2.
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maintained to establish an authentication reference for later
passages of the culture. If many different cell lines are
employed within a given laboratory, check the identity of
the cultures periodically, as such conditions increase the
cross-contamination risk. The identity of cell lines used for
studies to be published should be confirmed as part of the
manuscript submission process.
Animal cell authentication Cell culture species identifica-
tion is typically conducted through isoenzyme analysis
(e.g., Nims and Herbstritt 2005). More recently, DNA
amplification and barcoding technologies are gaining
increasing acceptance for this purpose (e.g., Cooper et al.
2007). Once the appropriate sets of species-specific loci are
established, SNP or STR profiling could also provide a
means of determining animal cell line authenticity to the
individual level. No consensus as to the role of STR or SNP
profiling methodologies for animal cell lines has thus far
been reached.
Limitations of SNP and STR profiling for cell authentica-
tion The primary drawback of the DNA profiling techni-
ques is an inability to detect interspecies cocultivation or
cross-contamination. If a research laboratory has cell lines
derived from multiple animal species in culture at any given
time, evaluation of those cell lines for species of origin may
be required over and above DNA profiling. At present,
DNA profiling cannot solely determine the species of
mixed cultures (human, mouse, hamster, etc.). To answer
that question, laboratories should retain isoenzyme analysis
or DNA amplification and barcoding as part of the
authentication armament even if STR or SNP profiling
become the definitive authentication practices for human
and animal cell lines. Karyotyping, while less useful for
routine authentication of human and animal cells, may need
to be kept as a quality control tool for STR profile data
prior to entry into a database.
What role should phenotyping play in cell authentication?
If a cell displays an expected phenotype, does this mean
that identity testing is not required? If a cell does not
display the expected phenotype, does this mean the cell is
incorrectly identified? The answer to both questions can be
no. A cell may display the expected phenotype (e.g.,
protein secretion, membrane protein status, etc.) and yet be
derived from a different source than that expected for the
cell (Dittmar et al. 2010). On the other hand, phenotypic
expression may change with passage of the cell or with
changes in cell environment (growth medium, other culture
conditions, etc.), so loss of an expected phenotype or gain
of a new phenotype neither confirms nor disputes that the
cell is incorrectly identified.
Anticipated impact of implementation of a consensus
standard This consensus standard will enable investigators
to comply with the evolving expectations of granting
agencies and scientific journals regarding cell authentica-
tion. The quality control criteria established within the
standard and the associated public STR database will
ensure an appropriate level of authentication stringency.
Will the standard’s implementation significantly reduce
the frequency of human cell line misidentification? The
answer depends upon a number of factors: (1) the level of
compliance with the standard across the biomedical
industry; (2) the extent to which granting agencies and
scientific journals accept the intent of the standard and
require adherence to it, and (3) the willingness of inves-
tigators to expend the necessary resources required to
adequately train their staff to follow good cell culture
practices and to authenticate their cells upon initial receipt
and periodically thereafter.
What about animal cells? Animal cell lines are used
extensively in biomedical research. Cell culture laboratories
typically maintain cells derived from multiple animal
species; therefore, a constant threat of cell line cross-
contamination and misidentification looms in most cell
culture facilities. As is the case for human cells, identity
testing is only one part of an overall strategy to reduce cell
misidentification frequency. Investigators must accept that
the problem exists and take the responsibility for fixing it.
A little gentle (or not so gentle) nudging from the scientific
journals and granting agencies will help to add the
necessary motivation. In the future, some version of STR
or SNP profiling may be implemented for non-human
animal cells. Until that time, and perhaps even thereafter,
isoenzyme analysis and DNA amplification and barcoding
will represent important tools for ensuring animal cell line
purity.
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